Moschidou, Dafni <br/><br/>
Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.  [electronic resource] 

 -  Stem cells and development  Feb 2013 
 - 444-58 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-8534 
<br/><br/><label>Standard No.: </label>10.1089/scd.2012.0267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amniotic Fluid--cytology<br/>Animals<br/>Antigens, Differentiation--genetics<br/>Cell Proliferation<br/>Cell Shape<br/>Cells, Cultured<br/>Culture Media<br/>Embryonic Stem Cells--metabolism<br/>Female<br/>Gene Expression<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Kruppel-Like Factor 4<br/>Kruppel-Like Transcription Factors--genetics<br/>Mesenchymal Stem Cells--metabolism<br/>Mice<br/>Neoplasms, Experimental--pathology<br/>Octamer Transcription Factor-3--genetics<br/>Pluripotent Stem Cells--drug effects<br/>Pregnancy<br/>Pregnancy Trimester, Second<br/>Proto-Oncogene Proteins c-myc--genetics<br/>SOXB1 Transcription Factors--genetics<br/>Telomere--metabolism<br/>Teratoma--pathology<br/>Up-Regulation--drug effects<br/>Valproic Acid--pharmacology